Ventricular Remodeling: Clinical Trials

8 trials for Ventricular Remodeling, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 48Completed 8

Follow Ventricular Remodeling: new trials by email Literature Review of Ventricular Remodeling trials Research Report on Ventricular Remodeling

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Henagliflozin Reducing Infarct Size After Priamry PCI in Patients With ST Segment Elevation Myocardial Infarction
Henagliflozin - Myocardial Infarction, Heart Failure
Phase 4CompletedQian geng2482023-07-012025-12-02
Peripartum Cardiomyopathy in Nigeria Registry
Oral Sodium Selenite 200 µg/day for 3 months - Peripartum Cardiomyopathy
Phase 4CompletedAminu Kano Teaching Hospital1002017-06-122021-01-22
Pulse Reduction On Beta-blocker and Ivabradine Therapy
Ivabradine, Placebo - Dilated Cardiomyopathies, Idiopathic, Heart Failure, Systolic
Phase 4CompletedUniversity of Colorado, Denver282016-11-012023-12-20
Danlou Tablets to Prevent Left Ventricular Remodeling
Danlou Tablets, Placebo - Left Ventricular Remodeling, Acute Myocardial Infarction
Phase 4Completedshuai Mao822012-01-012016-02-05
Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Patients With Slight Hypertension and Target Organ Damage
Valsartan 160mg plus HCT 25mg - Hypertension, Ventricular Remodeling
Phase 4CompletedFederico II University202008-03-012009-01-29
Statin Therapy in Heart Failure: Potential Mechanisms of Benefit
atorvastatin, placebo - Heart Failure, Congestive
Phase 4CompletedUniversity of California, Los Angeles272005-08-012020-03-20
Thrombectomy and Improvement of Left Ventricular Function in AMI
Export catheter (Medtronic) - Acute Myocardial Infarction, Ventricular Remodeling
Phase 4CompletedR&D Cardiologie502004-04-012006-02-08
Effect of Beta-blockers on Structural Remodeling and Gene Expression in the Failing Human Heart
Carvedilol, Metoprolol succinate, Metoprolol succinate + doxazosin - Idiopathic Dilated Cardiomyopathy
Phase 4CompletedUniversity of Colorado, Denver562000-09-012023-11-29

Narrower conditions

Cardiomyopathy, Dilated (2)  ·  Heart Failure (2)  ·  Myocardial Infarction (2)  ·  Atrial Remodeling (1)  ·  Erectile Dysfunction (1)  ·  Heart Failure, Systolic (1)  ·  Hypertension (1)  ·  Peripartum Cardiomyopathy (1)

Broader conditions

Pathological Conditions, Anatomical (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Cardiovascular Diseases (7)  ·  Heart Diseases (6)  ·  Cardiomyopathies (3)  ·  Pathologic Processes (3)  ·  Vascular Diseases (3)  ·  Cardiomegaly (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Genetic Diseases, Inborn (2)  ·  Infarction (2)  ·  Ischemia (2)  ·  Laminopathies (2)  ·  Myocardial Ischemia (2)  ·  Necrosis (2)

Interventions

Atorvastatin (1)  ·  Carvedilol (1)  ·  Doxazosin (1)  ·  Hematocrit (1)  ·  Ivabradine (1)  ·  Metoprolol (1)  ·  Sodium Selenite (1)  ·  Valsartan (1)  ·  danlou tablet (1)  ·  henagliflozin (1)

Sponsors

University of Colorado, Denver (2)  ·  Aminu Kano Teaching Hospital (1)  ·  Federico II University (1)  ·  Qian geng (1)  ·  R&D Cardiologie (1)  ·  University of California, Los Angeles (1)  ·  shuai Mao (1)

Countries

United States (3)  ·  China (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Nigeria (1)

Top investigators

Michael R Bristow, MD PhD (2)  ·  B. Rensing, MD, PhD (1)  ·  Kamilu M Karaye, PhD (1)  ·  Nan Bai, MD (1)  ·  Serafino Fazio, MD (1)  ·  Tamara B Horwich, MD (1)

Results publications

PMID 22041323, PMID 25637602, PMID 27056772, PMID 27825334, PMID 28132924, PMID 28138556, PMID 29142025, PMID 29311992, PMID 29932506, PMID 33087055, PMID 33397290, PMID 40052260

NIH funding

K23HL085097 (1), R01HL048013 (1)